3-nitro-N-hydroxybenzenesulfonamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-nitro-N-hydroxybenzenesulfonamide
• 英文别名: N-hydroxy-3-nitrobenzene-1-sulfonamide；N-hydroxy-3-nitrobenzenesulfonamide
• 化学式: C₆H₆N₂O₅S
• 分子量: 218.19
• InChiKey: YNYVAXYTOIAEND-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  121
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-羟基苯硫酚 、 3-nitro-N-hydroxybenzenesulfonamide 在 碘 、 potassium carbonate 作用下， 以 乙醇 为溶剂， 反应 6.0h， 以84%的产率得到S-4-hydroxyphenyl 3-nitrobenzenesulfonothioate
  参考文献：
  名称：

  An iodine-mediated new avenue to sulfonylation employing N-hydroxy aryl sulfonamide as a sulfonylating agent

  摘要：

  一种新颖且高效的I₂/K₂CO₃介导的对硫醚酚、芳基乙炔酸和芳基炔烃的选择性磺酰化方法，使用N-羟基磺胺酸盐。

  DOI：

  10.1039/d1ob00036e
• 作为产物：
  描述：

  3-硝基苯磺酰氯 在 盐酸羟胺 、 magnesium oxide 作用下， 以 甲醇 、 水 为溶剂， 反应 2.0h， 以95%的产率得到3-nitro-N-hydroxybenzenesulfonamide
  参考文献：
  名称：

  A Straightforward Route to Piloty’s Acid Derivatives: A Class of Potential Nitroxyl-Generating Prodrugs

  摘要：

  一系列Piloty的酸衍生物在温和且中性的条件下容易制备。最终产物易于分离，提供了显著优于知名工艺的优势。这种方法特别有吸引力，因为它能干净利落地提供低分子量的脂肪族磺酰羟肟酸，这些化合物因其生理条件下产生HNO的倾向而具有很大的研究价值。

  DOI：

  10.1055/s-0029-1217565

文献信息

• Chiral Cp^xRhodium(III)‐Catalyzed Enantioselective Aziridination of Unactivated Terminal Alkenes
  作者：Juanjuan Wang、Mu‐Peng Luo、Yi‐Jie Gu、Yu‐Ying Liu、Qin Yin、Shou‐Guo Wang

  DOI：10.1002/anie.202400502

  日期：2024.3.18

  A chiral cyclopentadienyl-rhodium(III) catalyzed highly enantioselective aziridination of challenging unactivated terminal alkenes and N-pivalolyloxy sulfonamides has been developed. This catalytic system demonstrated outstanding catalytic activity and broad functional group tolerance, yielding synthetically important and highly valuable chiral aziridines with good to excellent yields and enantioselectivities

  开发了一种手性环戊二烯基铑 (III) 催化的具有挑战性的未活化末端烯烃和N-新戊酰氧基磺酰胺的高度对映选择性氮丙啶化反应。该催化体系表现出出色的催化活性和广泛的官能团耐受性，产生具有合成重要性和高价值的手性氮丙啶，具有良好至优异的产率和对映选择性（高达 99% 的产率，93% ee）。
• N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
  申请人：Johns Hopkins University School of Medicine

  公开号：EP2489350A1

  公开（公告）日：2012-08-22

  The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release NHO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.

  本发明涉及N-羟基磺酰胺衍生物，该衍生物可在生理条件下捐献硝酰（HNO），并可用于治疗和/或预防对硝酰治疗有反应的疾病或病症的发生和/或发展，包括心力衰竭和缺血/再灌注损伤。新型 N- 羟基磺酰胺衍生物可在生理条件下以可控速率释放 NHO，HNO 释放速率可通过改变 N- 羟基磺酰胺衍生物上官能团的性质和位置来调节。
• Piloty’s acid derivative with improved nitroxyl-releasing characteristics
  作者：Kazuyuki Aizawa、Hidehiko Nakagawa、Kazuya Matsuo、Kodai Kawai、Naoya Ieda、Takayoshi Suzuki、Naoki Miyata

  DOI：10.1016/j.bmcl.2013.02.062

  日期：2013.4

  Recent studies have shown that nitroxyl (HNO) ((HNO)-H-1/(NO)-N-3 ), which is the one-electron-reduced form of nitric oxide (NO), has unique biological activities, especially in the cardiovascular system, and HNO-releasing agents may have therapeutic potential. Since few HNO donors are available for use under physiological conditions, we synthesized and evaluated a series of Piloty's acid (PA) derivatives and evaluated their HNO-releasing activity under physiological conditions. N-Hydroxy-2-nitrobenzenesulfonamide (17) was the most efficient HNO donor among our synthesized PA derivatives, including the lead compound, 2-bromo-N-hydroxybenzenesulfonamide (2). The high HNO-releasing activity is suggested to be due to electronic and steric effects. Compound 17 may be a useful tool for biological experiments. (C) 2013 Elsevier Ltd. All rights reserved.
• N-Hydroxylsulfonamide Derivatives as New Physiologically Useful Nitroxyl Donors
  申请人：Toscano John P.

  公开号：US20110306614A1

  公开（公告）日：2011-12-15

  The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release NHO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.
• N-HYDROXYLSULFONAMIDE DERIVATIVES AS NEW PHYSIOLOGICALLY USEFUL NITROXYL DONORS
  申请人：Cardioxyl Pharmaceuticals, Inc.

  公开号：US20140336396A1

  公开（公告）日：2014-11-13

  The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release NHO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.